GlassScriptPhysician profile
Harold J Davis
NPI 1427028950
$21,999.41
in general payments reported to CMS, 2019-2025
24 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,742 · 2020: $56.27 · 2021: $3,079 · 2022: $4,551 · 2023: $4,433 · 2024: $2,988 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,079 · Food and Beverage: $433 · Consulting Fee: $40.00 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,079.19 |
| Food and Beverage | $432.53 |
| Consulting Fee | $40.00 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $14,372.90 | 2021-2024 | Nexplanon |
| Merck Sharp & Dohme LLC | $6,516.58 | 2019 | |
| Abbvie INC. | $230.79 | 2019-2024 | Lo Loestrin Fe, Orilissa |
| Pfizer INC. | $142.27 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $112.97 | 2023-2025 | Gemtesa, Myfembree |
| Coloplast Corp | $68.90 | 2020-2021 | |
| Astellas Pharma US INC | $66.95 | 2024-2025 | Veozah |
| Exeltis, USA INC. | $65.90 | 2022-2025 | Slynd |
| Myovant Sciences INC. | $59.30 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.41 | 2022-2024 | |
| Mayne Pharma Commercial LLC | $46.71 | 2021-2025 | |
| Hologic Sales and Service, LLC | $45.96 | 2019-2025 | Novasure, Omni Hysteroscope |
| Olympus America INC. | $38.16 | 2019 | |
| Meditrina | $28.55 | 2022-2025 | |
| Avion Pharmaceuticals | $26.66 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $15.30 | 2025 | Pico 7, Pico 14 |
| Millicent US INC | $15.27 | 2025 | Intrarosa, Femlyv |
| Exact Sciences Corporation | $15.08 | 2025 | The Cologuard Plus Collection Kit |
| Allergan, INC. | $13.93 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.41 | 2019 | |
| Therapeuticsmd, INC. | $12.79 | 2019 | |
| Amgen INC. | $11.47 | 2019 | |
| Minerva Surgical, INC | $11.24 | 2019 | |
| Lupin INC. | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.